Preoperative/neoadjuvant medical therapy for early breast cancer
- 1 September 2001
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 2 (9), 561-570
- https://doi.org/10.1016/s1470-2045(01)00490-9
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trialBreast Cancer Research and Treatment, 1999
- Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-upAnnals Of Oncology, 1999
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancerAnnals Of Oncology, 1994
- Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cmAnnals Of Oncology, 1991
- A HUMAN TUMOUR MODELThe Lancet, 1986
- A Personal Experience with Halstedʼs Radical MastectomyAnnals of Surgery, 1984
- Multimodal treatment of locoregionally advanced breast cancerCancer, 1983
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerCancer Chemotherapy and Pharmacology, 1978